[Optimum Volume of Water Needed for the Paste State of Pediatric Powders: Considerations Based on Yield Values and Applications to Generic Medicine].


Journal

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
ISSN: 1347-5231
Titre abrégé: Yakugaku Zasshi
Pays: Japan
ID NLM: 0413613

Informations de publication

Date de publication:
2019
Historique:
entrez: 5 2 2019
pubmed: 5 2 2019
medline: 23 4 2019
Statut: ppublish

Résumé

To clarify the volume of water required to paste pediatric powders, we herein established a standard for the powder paste state by measuring yield values when water was added to powders. The powders used in the present study were selected from 8 types including original and generic drugs. Tipepidine hibenzate is prescribed in the pediatric field in combination with ambroxol hydrochloride and l-carbocysteine. The volumes of water needed to achieve the paste state of ambroxol hydrochloride between the original and generic drugs were similar. However, the volumes of water needed for l-carbocysteine markedly differed between the original and generic drugs due to differences in their additives. The spreadability of the mixture when water was added to the powders was evaluated using a spread meter. Among the powders tested in the present study, the yield value to achieve a paste state with the addition of water was approximately 1000 dyne/cm

Identifiants

pubmed: 30713242
doi: 10.1248/yakushi.18-00182
doi:

Substances chimiques

Adjuvants, Pharmaceutic 0
Drugs, Generic 0
Ointments 0
Piperidines 0
Powders 0
Water 059QF0KO0R
Ambroxol 200168S0CL
tipepidine 2260ZP67IT
Carbocysteine 740J2QX53R

Types de publication

Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Pagination

299-308

Auteurs

Haruka Fukuda (H)

Iris Pharma Corporation.

Toyofumi Suzuki (T)

Laboratory of Pharmaceutics, Nihon University School of Pharmacy.

Kaname Hashizaki (K)

Laboratory of Physical Chemistry, Nihon University School of Pharmacy.

Sayaka Yoshimura (S)

Laboratory of Pharmaceutics, Nihon University School of Pharmacy.

Chika Kobayashi (C)

Laboratory of Pharmaceutics, Nihon University School of Pharmacy.

Yosiko Omotani (Y)

Iris Pharma Corporation.

Naoto Suzuki (N)

Laboratory of Pharmaceutics, Nihon University School of Pharmacy.

Takanori Kanazawa (T)

Laboratory of Pharmaceutics, Nihon University School of Pharmacy.

Toshiro Fukami (T)

Department of Pharmacutics, Meiji Pharmaceutical University.

Yoshihisa Yamamoto (Y)

Unit of Physical Pharmaceutics, Faculty of Pharmaceutical Sciences, Teikyo Heisei University.

Articles similaires

Animals Dietary Fiber Dextran Sulfate Mice Disease Models, Animal
Humans Melanoma Skin Neoplasms Antineoplastic Combined Chemotherapy Protocols Randomized Controlled Trials as Topic
Silicon Dioxide Water Hot Temperature Compressive Strength X-Ray Diffraction
1.00
Oryza Agricultural Irrigation Potassium Sodium Soil

Classifications MeSH